Cyprotex

About:

Cyprotex is a contract research organization specialized in preclinical absorption, distribution, metabolism, and excretion (ADME).

Website: http://cyprotex.com

Twitter/X: cyprotexplc

Description:

Cyprotex specialises in preclinical ADME Tox, both in vitro (laboratory experiments) and in silico (computer modelling). Cyprotex was founded in 1999, and in 2002 it was listed on the London Stock Exchange’s AIM Market (symbol CRX, information for investors). Our headquarters are in Macclesfield, UK, near Manchester.

Total Funding Amount:

$2.68M

Headquarters Location:

Macclesfield, Cheshire East, United Kingdom

Founded Date:

1999-01-01

Contact Email:

enquiries(AT)cyprotex.com

Founders:

David Leahy

Number of Employees:

51-100

Last Funding Date:

2010-08-17

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai